Carotenoid and peptide supplementation from Caulerpa sp. (sea grapes) extract mitigate metabolic syndrome in cholesterol-enriched diet rats via modulation of gut microbiota.

Authors

Rudy Kurniawan, Fahrul Nurkolis, Agussalim Bukhari, Andi Yasmin Syauki, Burhanudin Bahar, Andi Makbul Aman, Nurpudji Astuti Taslim

Published in

Diabetology & metabolic syndrome. Volume 17. Issue 1. Pages 333. Aug 14, 2025. Epub Aug 14, 2025.

Abstract

Metabolic syndrome (MetS) is a multifactorial disorder characterized by obesity, dyslipidemia, insulin resistance, and hypertension, increasing the risk of cardiovascular diseases and type 2 diabetes mellitus (T2DM). Recent evidence suggests that gut microbiome dysbiosis plays a significant role in MetS pathogenesis. Functional foods enriched with bioactive compounds, particularly those derived from marine sources, have emerged as promising interventions.
This study aimed to evaluate the effects of carotenoid and peptide supplementation from Caulerpa sp. (sea grapes) extract on metabolic syndrome and gut microbiome modulation in cholesterol-fat-enriched diet (CFED) rats.
A randomized preclinical trial was conducted using CFED-fed rats, supplemented with carotenoid and peptide extracts from Caulerpa sp. Metabolic parameters, lipid profiles, enzymatic activities, and inflammatory biomarkers were assessed. Additionally, gut microbiota composition was analyzed using high-throughput sequencing techniques.
Supplementation with Caulerpa sp. extracts significantly improved metabolic markers, including reductions in body weight gain, triglycerides, total cholesterol, low-density lipoprotein (LDL), and blood glucose levels, while increasing high-density lipoprotein (HDL) (p < 0.05). Enzymatic analysis revealed suppression of key metabolic enzymes, such as α-glucosidase and lipase, suggesting potential regulatory effects on lipid and carbohydrate metabolism. Moreover, gut microbiome analysis indicated increased microbial diversity and favorable shifts in bacterial taxa. Specifically, Faecalibacterium and Lactobacillus, known for their anti-inflammatory and metabolic benefits, were enriched, while Oscillospira, which has been associated with metabolic disorders, showed a decline. These microbial changes suggest a potential role of Caulerpa sp. in modulating gut health and systemic metabolism.
The findings demonstrate that carotenoid and peptide extracts from Caulerpa sp. effectively mitigate metabolic syndrome through metabolic regulation, gut microbiome modulation, and anti-inflammatory mechanisms. This study highlights Caulerpa sp. as a potential functional food for MetS management, paving the way for future clinical applications.
Not applicable.
[Image: see text]

PMID:
40813684
Bibliographic data and abstract were imported from PubMed on 17 Aug 2025.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.